DCAT
Enzene will be at DCAT, engaging in meaningful discussions on biologics and biosimilars.
Connect with us to:
– Discuss development and manufacturing solutions for your biologic’s pipelines.
– Explore biosimilar licensing and partnership opportunities for global markets.
Book a meeting with the Enzene team at DCAT 2026 to learn how we can support your progress from development to commercialization.
Book a meeting
Fields marked with a * are required
